SEVIKAR HCT cpr pell 40/5/25 mg 98 pce

7680615190087 CH-61519 C09DX03 02.07.2.

Reimbursement limitations:

SEVIKAR

Le traitement combiné de SEVIKAR/HCT et d'un antagoniste du calcium I.T. 02.06. et/ou d'un inhibiteur …

SEVIKAR HCT cpr pell 40/5/25 mg 98 pce
SEVIKAR HCT cpr pell 40/5/25 mg 98 pce
SEVIKAR HCT cpr pell 40/5/25 mg 98 pce
1 / 3
google

Details

Product number
6151904
CPT
-
Packaging group
98
Unit
Tablette(n)
Composition
olmesartanum medoxomilum 40 mg, amlodipinum 5 mg ut amlodipini besilas, hydrochlorothiazidum 25 mg, amylum pregelificatum, cellulosum microcristallinum silicificatum, carmellosum natricum conexum corresp. natrium 1.92 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, E 171, talcum, E 172 (flavum), pro compresso obducto.

Articles (1)

Sevikar HCT 40 mg/5 mg/25 mg, Filmtabletten
Filmtabletten
98
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
25/06/2025
Patient information leaflet
Français
25/06/2025
Patient information leaflet
Italien
25/06/2025
Professional SmPC
Allemand
25/06/2025
Professional SmPC
Français
25/06/2025
Professional SmPC
Italien
25/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.92 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 83.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2011

Authorization holder

Daiichi Sankyo (Schweiz) AG

8048 Zürich

Authorization information

Swissmedic authorization number
61519
Drug name
Sevikar HCT, Filmtabletten
Galenic form
FILM
ATC Code
C09DX03
Authorization status
Z
Dispensation category
B
First authorization
30/05/2011
Authorization expiration date
31/12/9999
IT number
02.07.2.
Domain
Human medicine
Field of application
Hypertonie

Packaging details

Description (FR)
SEVIKAR HCT cpr pell 40/5/25 mg 98 pce
Description (DE)
SEVIKAR HCT Filmtabl 40/5/25 mg 98 Stk
Market launch
30/05/2011
Narcotic (BTM)
No

Available generics

Co-Olmesartan Amlo Spirig HC, Filmtabletten
CHF 34.90
View
Co-Olmesartan Amlo Spirig HC, Filmtabletten
CHF 66.85
View
Co-Olmesartan Amlo Spirig HC, Filmtabletten
CHF 39.30
View
Co-Olmesartan Amlo Spirig HC, Filmtabletten
CHF 79.25
View
Co-Olmesartan Amlo Spirig HC, Filmtabletten
CHF 39.30
View
Co-Olmesartan Amlo Spirig HC, Filmtabletten
CHF 79.25
View
Co-Olmesartan Amlo Spirig HC, Filmtabletten
CHF 40.25
View
Co-Olmesartan Amlo Spirig HC, Filmtabletten
CHF 85.35
View
Co-Olmesartan Amlo Spirig HC, Filmtabletten
CHF 40.25
View
Co-Olmesartan Amlo Spirig HC, Filmtabletten
CHF 85.35
View

Other packaging sizes

SEVIKAR HCT cpr pell 20/5/12.5 mg 28 pce
28 TABL
View
SEVIKAR HCT cpr pell 20/5/12.5 mg 98 pce
98 TABL
View
SEVIKAR HCT cpr pell 40/5/12.5 mg 28 pce
28 TABL
View
SEVIKAR HCT cpr pell 40/5/12.5 mg 98 pce
98 TABL
View
SEVIKAR HCT cpr pell 40/10/12.5 mg 28 pce
28 TABL
View
SEVIKAR HCT cpr pell 40/10/12.5 mg 98 pce
98 TABL
View
SEVIKAR HCT cpr pell 40/5/25 mg 28 pce
28 TABL
View
SEVIKAR HCT cpr pell 40/10/25 mg 28 pce
28 TABL
View
SEVIKAR HCT cpr pell 40/10/25 mg 98 pce
98 TABL
View